Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

NPS and SmithKline Beecham extend osteoporosis agreement

Nov. 5, 1997

Labeling changes for Rezulin; FDA and manufacturer recommend liver function tests

Nov. 5, 1997

Novo Nordisk reports improved human insulin derivatives

Nov. 5, 1997

Phase III safety and efficacy data reported for one-alpha D2

Nov. 4, 1997

Preclinical results with Ergo Science's neuroendocrine resetting therapy

Nov. 4, 1997

Sequana and Glaxo Wellcome revise diabetes/obesity alliance

Nov. 4, 1997

Pamidronate for preventing glucocorticoid-induced osteoporosis

Nov. 3, 1997

New neurotransmitter implicated in hunger and satiety

Oct. 31, 1997

Antiprogestational agents available from the NIH

Oct. 31, 1997

NIAID researchers report advances in gene therapy for CGD

Oct. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...